Clinical trials
Phase 3 Parkinsonian Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 4 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adamas Pharmaceuticals, Inc. | 4 |
| AbbVie | 3 |
| Theravance Biopharma | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 9 |
| Parkinsonian Disorders | 9 |
| Dyskinesias | 4 |
| Brain Diseases | 3 |
| Central Nervous System Diseases | 3 |
| Movement Disorders | 3 |
| Nervous System Diseases | 3 |
| Neurodegenerative Diseases | 3 |
| Dizziness | 2 |
| Hypotension | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.